Transgene Biotek Receives Drug Manufacturing Licence

Transgene Biotek Ltd has announced that the Company has been granted Drug Manufacturing Licence dated September 06, 2007 under the Drugs and Cosmetics Act, 1940 and Rules made thereunder for manufacture of the following products :

1. TACROLIMUS
2. SIROLIMUS

The stock was trading at Rs.102.40, up by Rs.4.85 or 4.97%. The stock hit an intraday high of Rs.102.40 and low of Rs.102.40. The total traded quantity was 4037 compared to 2 week average of 12820.

Source : Equity Bulls

Keywords